Harmony Biosciences Holdings, Inc.
HRMY
$31.43
$0.491.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 239.46M | 200.49M | 184.73M | 201.27M | 186.04M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 239.46M | 200.49M | 184.73M | 201.27M | 186.04M |
| Cost of Revenue | 59.65M | 38.15M | 31.99M | 54.41M | 42.78M |
| Gross Profit | 179.81M | 162.34M | 152.74M | 146.86M | 143.26M |
| SG&A Expenses | 59.36M | 64.00M | 61.95M | 56.47M | 56.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 173.97M | 152.31M | 128.49M | 145.54M | 124.33M |
| Operating Income | 65.49M | 48.18M | 56.25M | 55.73M | 61.71M |
| Income Before Tax | 67.49M | 49.64M | 57.18M | 56.16M | 62.17M |
| Income Tax Expenses | 16.63M | 9.86M | 11.62M | 6.68M | 16.08M |
| Earnings from Continuing Operations | 50.87M | 39.78M | 45.56M | 49.48M | 46.09M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 50.87M | 39.78M | 45.56M | 49.48M | 46.09M |
| EBIT | 65.49M | 48.18M | 56.25M | 55.73M | 61.71M |
| EBITDA | 71.46M | 54.15M | 62.21M | 61.70M | 67.68M |
| EPS Basic | 0.88 | 0.69 | 0.80 | 0.87 | 0.81 |
| Normalized Basic EPS | 0.73 | 0.54 | 0.62 | 0.61 | 0.68 |
| EPS Diluted | 0.87 | 0.68 | 0.78 | 0.85 | 0.79 |
| Normalized Diluted EPS | 0.72 | 0.53 | 0.61 | 0.60 | 0.67 |
| Average Basic Shares Outstanding | 57.55M | 57.47M | 57.31M | 57.10M | 56.87M |
| Average Diluted Shares Outstanding | 58.72M | 58.43M | 58.52M | 58.22M | 58.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |